Cargando…
P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429338/ http://dx.doi.org/10.1097/01.HS9.0000968912.12181.3e |
| _version_ | 1785090687770820608 |
|---|---|
| author | Baruchel, André Bertrand, Yves Nysom, Karsten Jin Kang, Hyoung Makiya, Monica Abrahamsson, Jonas González-Llano, Oscar Quinones Choque, Willy Rizzari, Carmelo Buechner, Jochen Cesaro, Simone Duarte, Ximo Fagioli, Franca Kattamis, Antonis Leverger, Guy Nelken, Brigitte Wang, Lynn Mace, Sandrine Oprea, Corina Abbadessa, Giovanni Zwaan, Michel |
| author_facet | Baruchel, André Bertrand, Yves Nysom, Karsten Jin Kang, Hyoung Makiya, Monica Abrahamsson, Jonas González-Llano, Oscar Quinones Choque, Willy Rizzari, Carmelo Buechner, Jochen Cesaro, Simone Duarte, Ximo Fagioli, Franca Kattamis, Antonis Leverger, Guy Nelken, Brigitte Wang, Lynn Mace, Sandrine Oprea, Corina Abbadessa, Giovanni Zwaan, Michel |
| author_sort | Baruchel, André |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429338 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293382023-08-17 P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS Baruchel, André Bertrand, Yves Nysom, Karsten Jin Kang, Hyoung Makiya, Monica Abrahamsson, Jonas González-Llano, Oscar Quinones Choque, Willy Rizzari, Carmelo Buechner, Jochen Cesaro, Simone Duarte, Ximo Fagioli, Franca Kattamis, Antonis Leverger, Guy Nelken, Brigitte Wang, Lynn Mace, Sandrine Oprea, Corina Abbadessa, Giovanni Zwaan, Michel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429338/ http://dx.doi.org/10.1097/01.HS9.0000968912.12181.3e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Baruchel, André Bertrand, Yves Nysom, Karsten Jin Kang, Hyoung Makiya, Monica Abrahamsson, Jonas González-Llano, Oscar Quinones Choque, Willy Rizzari, Carmelo Buechner, Jochen Cesaro, Simone Duarte, Ximo Fagioli, Franca Kattamis, Antonis Leverger, Guy Nelken, Brigitte Wang, Lynn Mace, Sandrine Oprea, Corina Abbadessa, Giovanni Zwaan, Michel P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title | P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title_full | P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title_fullStr | P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title_full_unstemmed | P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title_short | P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS |
| title_sort | p501: isatuximab plus chemotherapy for pediatric relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia (isakids): interim efficacy analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429338/ http://dx.doi.org/10.1097/01.HS9.0000968912.12181.3e |
| work_keys_str_mv | AT baruchelandre p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT bertrandyves p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT nysomkarsten p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT jinkanghyoung p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT makiyamonica p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT abrahamssonjonas p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT gonzalezllanooscar p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT quinoneschoquewilly p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT rizzaricarmelo p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT buechnerjochen p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT cesarosimone p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT duarteximo p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT fagiolifranca p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT kattamisantonis p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT levergerguy p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT nelkenbrigitte p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT wanglynn p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT macesandrine p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT opreacorina p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT abbadessagiovanni p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis AT zwaanmichel p501isatuximabpluschemotherapyforpediatricrelapsedrefractoryacutelymphoblasticleukemiaoracutemyeloidleukemiaisakidsinterimefficacyanalysis |